Expression of the inhibin/activin subunits alpha (α), beta-A (βA) and beta-B (βB) in benign human endometrial polyps and tamoxifen-associated polyps

Archives of Gynecology and Obstetrics

Volumn 272, Issue 1, 2005, Pages 59-66

  Mylonas, Ioannis ^a,b   Makovitzky, Josef ^b   Fernow, Anja ^b   Richter, Dagmar Ulrike ^b   Jeschke, Udo ^a   Briese, Volker ^b   Gerber, Bernd ^a   Friese, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Endometrial polyps; Endometrium; Immunohistochemistry; Inhibin activin subunits; Tamoxifen

Indexed keywords

INHIBIN A; INHIBIN B; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT; TAMOXIFEN;

ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG INDUCED CANCER; DRUG INDUCED DISEASE; ENDOMETRIUM; ENDOMETRIUM POLYP; ENDOMETRIUM TUMOR; EPITHELIUM CELL; FEMALE; HORMONE DEPENDENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SAMPLE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION;

ANTINEOPLASTIC AGENTS, HORMONAL; CASE-CONTROL STUDIES; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBIN-BETA SUBUNITS; INHIBINS; POLYPS; REGRESSION ANALYSIS; TAMOXIFEN; UTERINE DISEASES;

EID: 21244493651     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-004-0666-2     Document Type: Article

References (40)

1. Kurman RJ, Kaminski PF, Norris HJ (1985) The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 56:403-412
2. Mittal K, Schwartz L, Goswami S, Demopoulos R (1996) Estrogen and progesterone receptor expression in endometrial polyps. Int J Gynecol Pathol 15:345-348
3. Savelli L, De Iaco P, Santini D, Rosati F, Ghi T, Pignotti E, Bovicelli L (2003) Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol 188:927-931
4. Dal Cin P, Vanni R, Marras S, Moerman P, Kools P, Andria M, Valdes E, Deprest J, Van de Yen W, Van den Berghe H (1995) Four cytogenetic subgroups can be identified in endometrial polyps. Cancer Res 55:1565-1568
5. Ismail SM (1998) Endometrial changes during tamoxifen treatment. Lancet 351:838
6. Ismail SM (1994) Pathology of endometrium treated with tamoxifen. J Clin Pathol 47:827-833
7. Vosse M, Renard F, Coibion M, Neven P, Nogaret JM, Hertens D (2002) Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring. Eur J Obstet Gynecol Reprod Biol 101:58-63
8. Silva EG, Tornos CS, Follen-Mitchell M (1994) Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen. Int J Gynecol Pathol 13:248-258
9. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin W, Sawchenko P et al (1988) Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 44:1-34
10. Ying SY (1988) Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9:267-293
11. De Kretser DM, Hedger MP, Loveland KL, Phillips DJ (2002) Inhibins, activins and follistatin in reproduction. Hum Reprod Update 8:529-541
12. Welt CK (2002) The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction. Curr Opin Obstet Gynecol 14:317-323
13. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A (1992) Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313-319
14. Leung PH, Salamonsen LA, Findlay JK (1998) Immunolocalization of inhibin and activin subunits in human endometrium across the menstrual cycle. Hum Reprod 13:3469-3477
15. Jones RL, Salamonsen LA, Critchley HO, Rogers PA, Affandi B, Findlay JK (2000) Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception. Mol Hum Reprod 6:1107-1117
16. Mylonas I, Jeschke U, Wiest I, Hoeing A, Shabani N, Kuhn C, Schulze S, Kupka MS, Friese K (2004) Inhibin/activin subunits alpha (-α), beta-A (-βA) and beta-B (-βB) are differentially expressed in normal human endometrium throughout the menstrual cycle. Histochem Cell Biol (in press)
17. Jones RL, Salamonsen LA, Findlay JK (2002) Potential roles for endometrial inhibins, activins and follistatin during human embryo implantation and early pregnancy. Trends Endocrinol Metab 13:144-150
18. Dallenbach-Hellweg G, Poulsen H (1985) Atlas der Histopathologie des Endometriums. Springer, Berlin Heidelberg New York
19. Mylonas I, Makovitzky J, Richter DU, Jeschke U, Briese V, Friese K (2003) Immunohistochemical expression of the tumour marker CA-125 in normal, hyperplastic and malignant endometrial tissue. Anticancer Res 23:1075-1080
20. Mylonas I, Makovitzky J, Richter DU, Jeschke U, Briese V, Friese K (2003) Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Acta Histochem 105:245-252
21. Remmele W, Stegner HE (1987) Vorschlag zur einheitlichen Definierung eines immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptornachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe 8:138-140
22. Mylonas I, Jeschke U, Winkler L, Makovitzky J, Richter DU, Briese V, Friese K (2003) Immunohistochemical expression of inhibin-alpha in human endometrium and the in vitro secretion of inhibin, estradiol and cortisol in cultured human endometrial glandular cells. Arch Gynecol Obstet 268:142-150
23. Mylonas I, Makovitzky J, Richter DU, Jeschke U, Briese V, Friese K (2004) Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Gynecol Oncol 93:92-97
24. Nuovo MA, Nuovo GJ, McCaffrey RM, Levine RU, Barron B, Winkler B (1989) Endometrial polyps in postmenopausal patients receiving tamoxifen. Int J Gynecol Pathol 8:125-131
25. Maia H, Maltez A, Calmon LC, Oliveira M, Marques D, Coutinho EM (1998) Histopathology and steroid receptors in endometrial polyps of postmenopausal patients under hormone replacement therapy. Gynecol Endosc 7:267-272
26. Taylor LJ, Jackson TL, Reid JG, Duffy SR (2003) The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. Br J Obstet Gynaecol 110:794-798
27. Petraglia F, Florio P, Luisi S, Gallo R, Gadducci A, Vigano P, Di Blasio AM, Genazzani AR, Vale W (1998) Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. J Clin Endocrinol Metab 83:1194-1200
28. Mylonas I, Winkler L, Jeschke U, Briese V, Friese K (2003) Investigations on isolation, purification and cultivation of human endometrial cells and on the in vitro inhibin expression in glandular epithelial cells. Zentralbl Gynakol 125:415-423
29. Hubner G, Alzheimer C, Werner S (1999) Activin: a novel player in tissue repair processes. Histol Histopathol 14:295-304
30. Ni X, Luo S, Minegishi T, Peng C (2000) Activin A in JEG-3 cells: potential role as an autocrine regulator of steroidogenesis in humans. Biol Reprod 62:1224-1230
31. Keelan JA, Zhou RL, Mitchell MD (2000) Activin A exerts both pro- and anti-inflammatory effects on human term gestational tissues. Placenta 21:38-43
32. Liu QY, Niranjan B, Gomes P, Gomm JJ, Davies D, Coombes RC, Buluwela L (1996) Inhibitory effects of activin on the growth and morphogenesis of primary and transformed mammary epithelial cells. Cancer Res 56:1155-1163
33. Ying SY, Zhang Z (1996) Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line. Breast Cancer Res Treat 37:151-160
34. McCarthy SA, Bicknell R (1993) Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem 268:23066-23071
35. Robinson GW, Hennighausen L (1997) Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 124:2701-2708
36. Li Q, Karam SM, Coerver KA, Matzuk MM, Gordon JI (1998) Stimulation of activin receptor II signaling pathways inhibits differentiation of multiple gastric epithelial lineages. Mol Endocrinol 12:181-192
37. Di Simone N, Schneyer AL, Caliandro D, Castellani R, Caruso A (2002) Regulation of endometrial adenocarcinoma cell proliferation by activin-A and its modulation by 17beta-estradiol. Mol Cell Endocrinol 192:187-195
38. Luisi S, Florio P, Reis FM, Petraglia F (2001) Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol 145:225-236
39. Dallenbach-Hellweg G, Schmidt D, Hellberg P, Bourne T, Kreuzwieser E, Doren M, Rydh W, Rudenstam G, Granberg S (2000) The endometrium in breast cancer patients on tamoxifen. Arch Gynecol Obstet 263:170-177
40. Cohen I, Beyth Y, Altaras MM, Shapira J, Tepper R, Cardoba M, Yigael D, Figer A, Fishman A, Berenhein J (1997) Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies. Gynecol Oncol 67:8-15